The offerings make this week the busiest for biotech and pharmaceutical IPOs since July 2021. Tweet on Startup Biotech IPO offering A trio of biotech companies’ Bicara, MBX and Zenasshares rose in theirRead More
AstraZeneca became the latest big pharma to buy a company focused on an emerging approach to fighting cancer known as radiopharmaceuticals. Tweet on AstraZeneca AstraZeneca became the latest big pharma to buy aRead More
Shares of Madrigal Pharmaceuticals jumped more than 13% Friday after its treatment for a fatty liver disease became the first medicine of its kind to receive approval from the Food and Drug Administration.Read More
CG Oncology Inc. shares jumped 53% after the biotechnology company raised $380 million in an initial public offering that was larger than originally planned. Tweet on Biotech IPO Biotech CG Oncology Up 53%Read More
Big pharma’s $10.1 billion deal splash is giving biotech stocks a lift. AbbVie, plans to buy cancer drug developer ImmunoGen for $31.26 a share in cash, marking about a 95% premium to Immunogen’sRead More
Moderna has erased $6.8 billion in market value this week after rival shotmaker Pfizer Inc. slashed its profit outlook late last Friday, sounding the alarm on dwindling demand for its Covid shots andRead More
Eli Lilly stock is poised to set a new record high after the company reported a surge in sales for its buzzy diabetes drug Mounjaro. Tweet on Eli Lilly stock Eli Lilly stockRead More
Eli Lilly’s planned purchase of Dice Therapeutics for $2.4 billion is a big win for the small biotech’s shareholders. It also meant that short sellers once again rolled their eyes in disbelief TweetRead More
A final decision by the Food and Drug Administration is expected later this month. The FDA seems likely to approve an experimental gene therapy to treat a rare disease. That is translating toRead More
Pharma on the trail again, as J&J seeks resolution in the biggest settlement Lawsuit in modern history! Lawyers for thousands of plaintiffs say they support the proposal, which the bankruptcy court must approveRead More
